Health, illness and cancer in Reunion Island: Health services in a diverse but aging French territory.


Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 30 09 2021
revised: 25 11 2021
accepted: 26 11 2021
pubmed: 12 1 2022
medline: 3 3 2022
entrez: 11 1 2022
Statut: ppublish

Résumé

The major social, cultural, economic and demographic changes in Reunion Island in the last 70 years have had effects on its population and the evolution of its public health issues. The demographic transition and changes in lifestyle have led to a rapidly aging population with increased needs for care for dependency and chronic illness such as cancers. The aim of this paper is to offer a review of the literature and ongoing research on health and cancer in Reunion Island. It reviews the recent literature on these changes, including the socio-demography of the population, the medical demography and cancer care infrastructure. It highlights the significant social inequalities of the island, and shows its medical demography and healthcare services are close to national averages. It then offers a review of publications on the experiences of health and illness in Reunion Island in a multicultural and postcolonial context, between medical pluralism and biomedicine. It then offers a focus on the epidemiology of three cancers, namely breast, cervical and prostate cancers. It concludes with a review of known ongoing research, and calls for a rapid adaptation of the organization of the medico-social system, in order to face Reunion Island's most pressing healthcare issues: chronic illnesses such as cancers, and dependency.

Identifiants

pubmed: 35012768
pii: S0007-4551(21)00573-7
doi: 10.1016/j.bulcan.2021.11.011
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-231

Informations de copyright

Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Meoïn Hagège (M)

Université Paris Est Créteil, IMRB, Inserm, 94010 Créteil, France. Electronic address: meoin.hagege@inserm.fr.

Emmanuel Chirpaz (E)

CHU de La Réunion, centre d'investigation clinique, 97410 Saint-Pierre, France.
Université Paris Est Créteil, IMRB, Inserm, 94010 Créteil, France; CHU de La Réunion, centre d'investigation clinique, 97410 Saint-Pierre, France; CHU de La Réunion, service d'hématologie-oncologie, 97410 Saint-Pierre, France; Université de La Réunion, Saint-Denis, France.

Mohamed Khettab (M)

CHU de La Réunion, centre d'investigation clinique, 97410 Saint-Pierre, France; CHU de La Réunion, service d'hématologie-oncologie, 97410 Saint-Pierre, France; Université de La Réunion, Saint-Denis, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH